Lucira Health, Inc. Increase (Decrease) in Accrued Liabilities
Lucira Health, Inc. reported Increase (Decrease) in Accrued Liabilities of -$3.24 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-11-14
- Lucira Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$5.26M.
- Lucira Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was -$12.06M, a 203.26% decline year-over-year.
- Lucira Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $14.09M, a 621.45% increase year-over-year.
- Lucira Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was $13.72M, a 654.68% increase year-over-year.
- Lucira Health, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $23.98M, a 766.15% increase from fiscal 2020.
- Lucira Health, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $2.77M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$17.33M derived: sum of 2 quarters · filed 2022-11-14 | -$3.24M 10-Q · filed 2022-11-14 | $10.48M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$12.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.03M 10-Q · filed 2022-08-15 | $15.75M derived: sum of 3 quarters · filed 2022-08-15 | $12.37M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $14.09M 10-Q · filed 2022-05-16 | $27.81M derived: sum of 2 quarters · filed 2022-05-16 | $24.43M derived: sum of 3 quarters · filed 2022-11-14 | $36.11M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $13.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $10.34M derived: sum of 2 quarters · filed 2022-11-14 | $22.02M derived: sum of 3 quarters · filed 2022-11-14 | $23.98M 10-K · filed 2022-03-31 |
| 2021-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.30M derived: sum of 2 quarters · filed 2022-11-14 | $10.26M 10-Q · filed 2022-11-14 | $12.07M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $11.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $13.63M 10-Q · filed 2022-08-15 | $15.45M derived: sum of 3 quarters · filed 2022-08-15 | $16.36M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-16 | $3.77M derived: sum of 2 quarters · filed 2022-05-16 | $4.67M derived: sum of 3 quarters · filed 2022-05-16 | $4.79M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.72M derived: sum of 2 quarters · filed 2022-03-31 | $2.84M derived: sum of 3 quarters · filed 2022-03-31 | $2.77M 10-K · filed 2022-03-31 |
| 2020-09-30 | $903.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.02M derived: sum of 2 quarters · filed 2021-11-12 | $950.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $47.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$69.00K 10-Q · filed 2021-05-17 |